Elanco Animal Health [ELAN] vs Regencell Bioscience [RGC] Detailed Stock Comparison

Elanco Animal Health

NYSE
Loading...

Regencell Bioscience

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Elanco Animal Health wins in 10 metrics, Regencell Bioscience wins in 4 metrics, with 0 ties. Elanco Animal Health appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricElanco Animal HealthRegencell BioscienceBetter
P/E Ratio (TTM)22.28-1,779.13Regencell Bioscience
Price-to-Book Ratio1.441,121.43Elanco Animal Health
Debt-to-Equity Ratio62.130.00Regencell Bioscience
PEG Ratio-0.19N/AN/A
EV/EBITDA15.93-1,913.48Regencell Bioscience
Profit Margin (TTM)9.68%0.00%Elanco Animal Health
Operating Margin (TTM)6.85%0.00%Elanco Animal Health
EBITDA Margin (TTM)6.85%N/AN/A
Return on Equity6.83%-47.77%Elanco Animal Health
Return on Assets (TTM)0.98%-30.65%Elanco Animal Health
Free Cash Flow (TTM)$380.00M$-4.01MElanco Animal Health
1-Year Return39.63%14,581.82%Regencell Bioscience
Price-to-Sales Ratio (TTM)2.17N/AN/A
Enterprise Value$13.41B$7.64BElanco Animal Health
EV/Revenue Ratio2.99N/AN/A
Gross Profit Margin (TTM)57.45%N/AN/A
Revenue per Share (TTM)$9$0Elanco Animal Health
Earnings per Share (Diluted)$0.88$-0.01Elanco Animal Health
Beta (Stock Volatility)1.622.15Elanco Animal Health
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Elanco Animal Health vs Regencell Bioscience Stock Performance Analysis

Loading Price Chart...

Elanco Animal Health
Regencell Bioscience
Elanco Animal Health Stock Overview | Regencell Bioscience Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Elanco Animal Health-1.59%8.19%14.68%39.06%90.06%69.88%
Regencell Bioscience2.02%6.67%25.68%55.89%2,504.84%12,323.08%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Elanco Animal Health39.63%66.69%-38.16%-39.97%-39.97%-39.97%
Regencell Bioscience14,581.82%1,845.78%5,667.86%5,667.86%5,667.86%5,667.86%

News Based Sentiment: Elanco Animal Health vs Regencell Bioscience

Elanco Animal Health

News based Sentiment: POSITIVE

Elanco experienced a strong month with a new 52-week high, positive earnings results, and upgrades from multiple analysts. The company is also investing in key areas like automation and high-performance computing, signaling a commitment to future growth. While institutional activity is mixed, the overall narrative is positive.

View Elanco Animal Health News Sentiment Analysis

Regencell Bioscience

News based Sentiment: POSITIVE

The month of October 2025 showed positive movement in investor sentiment with a decrease in short interest and a higher-than-average news sentiment score. However, the lack of insider and institutional activity tempers the overall outlook, suggesting a need for continued monitoring.

View Regencell Bioscience News Sentiment Analysis

Performance & Financial Health Analysis: Elanco Animal Health vs Regencell Bioscience

MetricELANRGC
Market Information
Market Cap i$9.74B$7.64B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i5,423,590183,082
90 Day Avg. Volume i8,718,383247,494
Last Close$20.47$16.15
52 Week Range$8.02 - $20.92$0.09 - $83.60
% from 52W High-2.15%-80.68%
All-Time High$37.61 (Sep 24, 2018)$950.00 (May 30, 2025)
% from All-Time High-45.57%-98.30%
Growth Metrics
Quarterly Revenue Growth0.05%N/A
Quarterly Earnings Growth0.05%N/A
Financial Health
Profit Margin (TTM) i0.10%0.00%
Operating Margin (TTM) i0.07%0.00%
Return on Equity (TTM) i0.07%-0.48%
Debt to Equity (MRQ) i62.130.00
Cash & Liquidity
Book Value per Share (MRQ)$13.64$0.01
Cash per Share (MRQ)$1.09N/A
Operating Cash Flow (TTM) i$572.00M$-3,881,392
Levered Free Cash Flow (TTM) i$1.21B$-4,301,837
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Elanco Animal Health vs Regencell Bioscience

MetricELANRGC
Price Ratios
P/E Ratio (TTM) i22.28-1,779.13
Forward P/E i20.86N/A
PEG Ratio i-0.19N/A
Price to Sales (TTM) i2.17N/A
Price to Book (MRQ) i1.441,121.43
Market Capitalization
Market Capitalization i$9.74B$7.64B
Enterprise Value i$13.41B$7.64B
Enterprise Value Metrics
Enterprise to Revenue i2.99N/A
Enterprise to EBITDA i15.93-1,913.48
Risk & Other Metrics
Beta i1.622.15
Book Value per Share (MRQ) i$13.64$0.01

Financial Statements Comparison: Elanco Animal Health vs Regencell Bioscience

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)ELANRGC
Revenue/Sales i$1.24BN/A
Cost of Goods Sold i$528.00MN/A
Gross Profit i$713.00MN/A
Research & Development i$92.00MN/A
Operating Income (EBIT) i$85.00MN/A
EBITDA i$243.00MN/A
Pre-Tax Income i$25.00MN/A
Income Tax i$14.00MN/A
Net Income (Profit) i$11.00MN/A

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)ELANRGC
Cash & Equivalents i$539.00M$2.96M
Total Current Assets i$3.61B$8.11M
Total Current Liabilities i$1.39B$193,578
Long-Term Debt i$4.15B$25,934
Total Shareholders Equity i$6.78B$8.22M
Retained Earnings i$-1.87B$-21.62M
Property, Plant & Equipment iN/A$84,780

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)ELANRGC
Operating Cash Flow i$185.00MN/A
Capital Expenditures i$-57.00MN/A
Free Cash Flow i$180.00MN/A
Debt Repayment i$-446.00MN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricELANRGC
Shares Short i27.38M1.68M
Short Ratio i2.686.07
Short % of Float i0.08%0.02%
Average Daily Volume (10 Day) i5,423,590183,082
Average Daily Volume (90 Day) i8,718,383247,494
Shares Outstanding i494.45M494.49M
Float Shares i492.94M18.43M
% Held by Insiders i0.01%0.96%
% Held by Institutions i1.10%0.00%

Dividend Analysis & Yield Comparison: Elanco Animal Health vs Regencell Bioscience

MetricELANRGC
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A